+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07491952

Evaluation of Continuous Dual Aspiration Technique Using Zoom System for Aspiration Neurothrombectomy in Ischemic Stroke

Led by Imperative Care, Inc. · Updated on 2026-10-20

750

Participants Needed

25

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

This research focuses on evaluating the use of the Zoom System with Continuous Dual Aspiration Technique CDAT as a first-line treatment for ischemic stroke. The study aims to assess its effectiveness, safety, and clinical performance in patients undergoing aspiration neurothrombectomy. It is an observational study designed to gather real-world data on this device. Participants receive treatment using the Zoom System as the primary device within its approved uses and anatomical targets. The procedure involves aspiration thrombectomy intended to remove blood clots causing stroke. The study observes patients treated with this technique to understand outcomes and procedural details. During the study, participants clinical progress is monitored, focusing on outcomes like the proportion achieving successful blood flow restoration mTICI score 2c, embolization rates, and time to reperfusion. Safety is tracked through imaging and adverse event reporting, with follow-up assessments at 24 hours and 90 days post-procedure. The study collects data on functional independence and mortality at 90 days, with participation lasting through these follow-up periods.

CONDITIONS

Brief Title

Continuous Dual Aspiration Technique With Zoom System for Stroke

Research Team

P

Pojai Phattanagosai

E

Emma Pham

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here